vs
ヘモネティクス（HAE）とIES Holdings, Inc.（IESC）の財務データ比較。上の社名をクリックして会社を切り替えられます
IES Holdings, Inc.の直近四半期売上が大きい（$871.0M vs $346.4M、ヘモネティクスの約2.5倍）。ヘモネティクスの純利益率が高く（28.1% vs 10.5%、差は17.6%）。IES Holdings, Inc.の前年同期比売上増加率が高い（16.2% vs 4.8%）。ヘモネティクスの直近四半期フリーキャッシュフローが多い（$209.9M vs $-18.9M）。過去8四半期でIES Holdings, Inc.の売上複合成長率が高い（11.1% vs 1.5%）
ヘモネティクスコーポレーションは血液・血漿の供給および関連サービスを提供するグローバル企業です。1970年代にマサチューセッツ州ネイティックでアレン・（ジャック）・レイサム博士によって設立され、世界中の医療分野に血液管理に関する専門的なソリューションを提供しています。
IES Holdings, Inc.は旧社名Integrated Electrical Services, Inc.で、統合電気・技術システムの設計・設置を手がけるほか、データセンター、住宅、商業施設・工業施設など多様な末端市場向けにインフラ関連製品・サービスを提供している。
HAE vs IESC — 直接比較
損益計算書 — Q4 FY2026 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $346.4M | $871.0M |
| 純利益 | $97.3M | $91.8M |
| 粗利率 | 57.2% | 25.3% |
| 営業利益率 | 36.1% | 11.2% |
| 純利益率 | 28.1% | 10.5% |
| 売上前年比 | 4.8% | 16.2% |
| 純利益前年比 | — | 59.1% |
| EPS（希薄化後） | — | $4.51 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $346.4M | — | ||
| Q4 25 | $339.0M | $871.0M | ||
| Q3 25 | $327.3M | $897.8M | ||
| Q2 25 | $321.4M | $890.2M | ||
| Q1 25 | $330.6M | $834.0M | ||
| Q4 24 | $348.5M | $749.5M | ||
| Q3 24 | $345.5M | $775.8M | ||
| Q2 24 | $336.2M | $768.4M |
| Q1 26 | $97.3M | — | ||
| Q4 25 | $44.7M | $91.8M | ||
| Q3 25 | $38.7M | $102.3M | ||
| Q2 25 | $34.0M | $79.3M | ||
| Q1 25 | $58.0M | $72.6M | ||
| Q4 24 | $37.5M | $57.7M | ||
| Q3 24 | $33.8M | $65.5M | ||
| Q2 24 | $38.4M | $66.6M |
| Q1 26 | 57.2% | — | ||
| Q4 25 | 59.7% | 25.3% | ||
| Q3 25 | 59.5% | 26.0% | ||
| Q2 25 | 59.8% | 26.9% | ||
| Q1 25 | 58.4% | 25.0% | ||
| Q4 24 | 55.5% | 23.8% | ||
| Q3 24 | 54.2% | 24.0% | ||
| Q2 24 | 52.0% | 25.3% |
| Q1 26 | 36.1% | — | ||
| Q4 25 | 19.9% | 11.2% | ||
| Q3 25 | 17.9% | 11.6% | ||
| Q2 25 | 16.8% | 12.6% | ||
| Q1 25 | 21.6% | 11.1% | ||
| Q4 24 | 16.9% | 10.0% | ||
| Q3 24 | 15.0% | 9.7% | ||
| Q2 24 | 11.8% | 11.7% |
| Q1 26 | 28.1% | — | ||
| Q4 25 | 13.2% | 10.5% | ||
| Q3 25 | 11.8% | 11.4% | ||
| Q2 25 | 10.6% | 8.9% | ||
| Q1 25 | 17.5% | 8.7% | ||
| Q4 24 | 10.8% | 7.7% | ||
| Q3 24 | 9.8% | 8.4% | ||
| Q2 24 | 11.4% | 8.7% |
| Q1 26 | — | — | ||
| Q4 25 | $0.95 | $4.51 | ||
| Q3 25 | $0.81 | $4.99 | ||
| Q2 25 | $0.70 | $3.81 | ||
| Q1 25 | $1.17 | $3.50 | ||
| Q4 24 | $0.74 | $2.72 | ||
| Q3 24 | $0.66 | $3.06 | ||
| Q2 24 | $0.74 | $2.67 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $245.4M | $258.7M |
| 総負債低いほど良い | $1.2B | — |
| 株主資本純資産 | $796.3M | $961.1M |
| 総資産 | $2.4B | $1.7B |
| 負債/資本比率低いほどレバレッジが低い | 1.53× | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $245.4M | — | ||
| Q4 25 | $363.4M | $258.7M | ||
| Q3 25 | $296.4M | $231.8M | ||
| Q2 25 | $292.9M | $168.3M | ||
| Q1 25 | $306.8M | $88.3M | ||
| Q4 24 | $320.8M | $112.0M | ||
| Q3 24 | $299.3M | $135.8M | ||
| Q2 24 | $344.4M | $44.9M |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $796.3M | — | ||
| Q4 25 | $911.5M | $961.1M | ||
| Q3 25 | $849.2M | $884.0M | ||
| Q2 25 | $882.3M | $781.4M | ||
| Q1 25 | $820.8M | $705.8M | ||
| Q4 24 | $906.9M | $652.4M | ||
| Q3 24 | $878.9M | $611.1M | ||
| Q2 24 | $905.4M | $567.5M |
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.5B | $1.7B | ||
| Q3 25 | $2.4B | $1.6B | ||
| Q2 25 | $2.5B | $1.5B | ||
| Q1 25 | $2.5B | $1.4B | ||
| Q4 24 | $2.5B | $1.3B | ||
| Q3 24 | $2.5B | $1.2B | ||
| Q2 24 | $2.5B | $1.2B |
| Q1 26 | 1.53× | — | ||
| Q4 25 | 1.34× | — | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 1.39× | — | ||
| Q1 25 | 1.49× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $293.2M | $27.7M |
| フリーキャッシュフロー営業CF - 設備投資 | $209.9M | $-18.9M |
| FCFマージンFCF / 売上 | 60.6% | -2.2% |
| 設備投資強度設備投資 / 売上 | 9.5% | 5.3% |
| キャッシュ転換率営業CF / 純利益 | 3.01× | 0.30× |
| 直近12ヶ月FCF直近4四半期 | $417.1M | $175.9M |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $293.2M | — | ||
| Q4 25 | $93.6M | $27.7M | ||
| Q3 25 | $111.3M | $132.0M | ||
| Q2 25 | $17.4M | $92.0M | ||
| Q1 25 | $116.6M | $24.8M | ||
| Q4 24 | $43.8M | $37.3M | ||
| Q3 24 | $48.8M | $92.8M | ||
| Q2 24 | $-27.4M | $82.9M |
| Q1 26 | $209.9M | — | ||
| Q4 25 | $87.2M | $-18.9M | ||
| Q3 25 | $106.3M | $112.0M | ||
| Q2 25 | $13.6M | $74.8M | ||
| Q1 25 | $100.9M | $7.9M | ||
| Q4 24 | $35.2M | $24.1M | ||
| Q3 24 | $39.4M | $78.5M | ||
| Q2 24 | $-33.1M | $65.4M |
| Q1 26 | 60.6% | — | ||
| Q4 25 | 25.7% | -2.2% | ||
| Q3 25 | 32.5% | 12.5% | ||
| Q2 25 | 4.2% | 8.4% | ||
| Q1 25 | 30.5% | 0.9% | ||
| Q4 24 | 10.1% | 3.2% | ||
| Q3 24 | 11.4% | 10.1% | ||
| Q2 24 | -9.8% | 8.5% |
| Q1 26 | 9.5% | — | ||
| Q4 25 | 1.9% | 5.3% | ||
| Q3 25 | 1.5% | 2.2% | ||
| Q2 25 | 1.2% | 1.9% | ||
| Q1 25 | 4.7% | 2.0% | ||
| Q4 24 | 2.5% | 1.8% | ||
| Q3 24 | 2.7% | 1.8% | ||
| Q2 24 | 1.7% | 2.3% |
| Q1 26 | 3.01× | — | ||
| Q4 25 | 2.09× | 0.30× | ||
| Q3 25 | 2.88× | 1.29× | ||
| Q2 25 | 0.51× | 1.16× | ||
| Q1 25 | 2.01× | 0.34× | ||
| Q4 24 | 1.17× | 0.65× | ||
| Q3 24 | 1.44× | 1.42× | ||
| Q2 24 | -0.71× | 1.24× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
HAE
| Hospital | $159.6M | 46% |
| Plasma | $130.3M | 38% |
| Blood Center | $56.4M | 16% |
IESC
| Communications | $351.9M | 40% |
| Single Family Electrical Contracts | $137.0M | 16% |
| Custom Engineered Solutions | $116.0M | 13% |
| Commercialand Industrial | $94.8M | 11% |
| Single Family Contracts Plumbing HVAC | $82.9M | 10% |
| Multi Familyand Other | $64.2M | 7% |
| Industrial Services | $24.2M | 3% |
